Stock Price
145.11
Daily Change
0.11 0.08%
Monthly
-20.67%
Yearly
-45.20%
Q1 Forecast
150.05

CSL reported $2.06 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Arca Biopharma USD -0.5 0.08 Mar/2025
aTyr Pharma USD -0.26 0.05 Sep/2025
Bio Path USD -0.4 0.33 Mar/2025
Brainstorm Cell Therapeutics USD -0.45 0.06 Mar/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
CSL USD 2.06 2.2 Jun/2025
Curis USD -2.03 0.02 Jun/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024